Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 1;5(2):267-269.
doi: 10.1001/jamaoncol.2018.6643.

Assessment of Radiotherapy-Associated Angiosarcoma After Breast Cancer Treatment in a Dutch Population-Based Study

Anouk J M Rombouts  1 , Jonathan Huising  1 , Niek Hugen  1 , Sabine Siesling  2   3 , Philip Martin Poortmans  4   5 , Iris D Nagtegaal  6 , Johannes H W de Wilt  1
Affiliations

Assessment of Radiotherapy-Associated Angiosarcoma After Breast Cancer Treatment in a Dutch Population-Based Study

Anouk J M Rombouts et al. JAMA Oncol. .

Abstract

This population-based study describes the incidence, latency period, and outcomes of radiotherapy-associated angiosarcoma among patients with breast cancer from the Netherlands Cancer Registry.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Overview of Latency Periods Between Diagnosis of Primary Breast Cancer and Diagnosis of Secondary Sarcoma
Includes 209 patients with breast cancer and treated with radiotherapy ascertained from the Netherlands Cancer Registry.
See this image and copyright information in PMC

References

    1. Depla AL, Scharloo-Karels CH, de Jong MA, et al. . Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J Cancer. 2014;50(10):1779-1788. doi:10.1016/j.ejca.2014.03.002 - DOI - PubMed
    1. Torres KE, Ravi V, Kin K, et al. . Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013;20(4):1267-1274. doi:10.1245/s10434-012-2755-y - DOI - PMC - PubMed
    1. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509. doi:10.1080/01621459.1999.10474144 - DOI
    1. Yap J, Chuba PJ, Thomas R, et al. . Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(5):1231-1237. doi:10.1016/S0360-3016(01)02799-7 - DOI - PubMed
    1. Huang J, Mackillop WJ. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer. 2001;92(1):172-180. doi:10.1002/1097-0142(20010701)92:1<172::AID-CNCR1306>3.0.CO;2-K - DOI - PubMed

MeSH terms

Supplementary concepts